होमAthleticsRuti Aga: Six Years, Two for the Drug and Four for a Prescription That Was Never Written
Athletics

Ruti Aga: Six Years, Two for the Drug and Four for a Prescription That Was Never Written

**मुख्य उत्तर**: इथियोपियाई मैराथन धावक रूति आगा (32) को एथलेटिक्स इंटीग्रिटी यूनिट (AIU) ने छह साल का प्रतिबंध दिया — दो साल मिथाइलप्रेडनिसोलोन (WADA क्लास S9 ग्लूकोकोर्टिकॉइड) के इन-कम्पटीशन पॉज़िटिव टेस्ट पर और चार साल जाँच में गुमराह करने पर। प्रतिबंध 10 सितंबर से बैकडेटेड है। **मुख्य तथ्य**: - मार्च में चीन में जीती गई हाफ मैराथन के बाद लिए गए सैंपल में मिथाइलप्रेडनिसोलोन पाया गया। - मिथाइलप्रेडनिसोलोन ग्लूकोकोर्टिकॉइड (क्लास S9) है, एनाबॉलिक स्टेरॉयड (क्लास S1) नहीं; यह केवल इन-कम्पटीशन प्रतिबंधित है। - फर्जी प्रिस्क्रिप्शन परिवार के एक सदस्य ने लिखा, जिसका मेडिकल रजिस्ट्रेशन नहीं था और जिसका बताया गया क्लिनिक अस्तित्व में नहीं है। - आगा 10 सितंबर से प्रोविज़नल सस्पेंशन में थीं; प्रतिबंध ख़त्म होने पर उनकी उम्र लगभग 38 होगी। - आगा 2019 टोक्यो मैराथन विजेता हैं और वर्ल्ड मैराथन मेजर्स में तीन बार दूसरे स्थान पर रही हैं। **स्रोत**: Athletics Integrity Unit (AIU) की आधिकारिक विज्ञप्ति; प्रकाशन की सटीक तिथि मूल रिपोर्ट में नहीं दी गई है। **संबंधित प्रश्नोत्तर**: प्रश्न: क्या ग्लूकोकोर्टिकॉइड इंजेक्शन हमेशा डोपिंग उल्लंघन है? उत्तर: नहीं — S9 दवाएँ केवल प्रतियोगिता के दौरान और केवल इंजेक्शन, मुँह या रेक्टल रूट से प्रतिबंधित हैं; प्रतियोगिता से बाहर चिकित्सीय उपयोग वैध है। प्रश्न: रूति आगा को छह साल का प्रतिबंध कैसे मिला? उत्तर: दो साल दवा की उपस्थिति (Specified Substance) पर और चार साल टैम्परिंग की मानक सज़ा पर — जोड़ 10 सितंबर से बैकडेटेड है। प्रश्न: क्या उनके 2019 टोक्यो मैराथन खिताब पर असर पड़ा? उत्तर: AIU बयान में रद्दीकरण का दायरा स्पष्ट नहीं किया गया; मार्च वाली रेस का नतीजा और इनामी रकम सवालों में है, लेकिन पहले के नतीजे अपने-आप रद्द नहीं होते।

The most expensive piece of paper in athletics this year wasn't a results sheet. It was a prescription slip. It carried the name of a clinic that does not exist, the signature of a man with no medical registration, and a claim — offered in interview — that he had used an old prescription pad from a former workplace that has since disowned him. On that single slip, the 32-year-old Ethiopian marathoner Ruti Aga received a six-year ban.

I am one of those reporters who carries his own stopwatch into a stadium, because the number glowing on the board often looks cleaner than it has any right to. In 2026, from the stands at the Kalinga Stadium in Bhubaneswar, I hand-timed the anchor leg of the men's 4x400m relay at the Asian Athletics Championships and found my splits disagreed with the stadium announcer. I checked my own working overnight, annoyed a senior colleague in the press box, and published the correction the next morning. The method hasn't changed since: take the number you were handed and re-add it yourself.

In Aga's case the board carried no mark, only sanction arithmetic. The Athletics Integrity Unit (AIU) statement laid out two separate penalties — two years for the presence of a prohibited substance in a sample taken after she won a half marathon in China in March, and four years for tampering with the investigation. Add them: six. Her provisional suspension had been running since 10 September, and the ban is backdated to the same date. Nowhere in any statement is there a time, a split or a field description for that March race. Writing a performance verdict on a race whose clock was never disclosed would be invention, not analysis.

This is where the coverage went wrong. Methylprednisolone was described as a "prohibited steroid" and as "classed as performance enhancing by WADA." Methylprednisolone is not an anabolic steroid; it is a glucocorticoid, class S9 on the WADA Prohibited List, prohibited in-competition only, and only by injection, oral or rectal route. Anabolic steroids sit in S1, banned at all times. The distinction is technical, and the entire case turns on it.

Ruti Aga: Six Years, Two for the Drug and Four for a Prescription That Was Never Written

Because with an S9 drug the question is never "did she take it" but "when and how." A therapeutic injection into a swollen knee, administered out of competition, is entirely legal. The same injection becomes an in-competition positive if residues are still present on race day. A road race's testing window opens at 23:59 the night before the race — so an injection given days before that March half marathon was always going to be caught.

Ruti Aga: Six Years, Two for the Drug and Four for a Prescription That Was Never Written

Here is the part that stings. Intra-articular methylprednisolone for knee synovitis is routine sports medicine in distance runners, and Aga herself cited a knee injury. A legitimate defence existed: real medical records, the injection date, the route, and an argument around a Therapeutic Use Exemption (TUE). An athlete with a truthful route to acquittal closed that route herself by manufacturing a prescription. That is a self-destructive decision, and it says more about the medical environment around her than about her alone.

Read the arithmetic again, because the arithmetic talks. The two years cover a case where intent was not proven — the panel treated the substance as specified but rejected the no-significant-fault mitigation that would have cut the period further. The four years are the Code's standard tampering sanction. Two years for the drug, four for the paperwork — that is where the six comes from. The backdating is procedural housekeeping, not a discount: time already served on provisional suspension simply counts.

The age curve needs no elaboration. Thirty-two, six years from 10 September, a return at 38. Ethiopia's women's marathon depth is such that a 2:18 performer is not automatically selectable; a 38-year-old with a doping record is effectively unselectable. Her 2026 Tokyo Marathon title and three World Marathon Majors runner-up finishes remain on the record. The March result and its prize money are almost certainly void, though the AIU statement did not spell out the disqualification scope, and earlier results do not fall automatically.

One element has gone almost unnoticed: China's label-race circuit. For East African marathoners it is the lucrative, low-risk income tier between Majors. It is also now the AIU's highest-yield testing ground. The fee-paying economy and the testing economy are colliding in the same races.

Now the easiest reading, and I will state it in its strongest form because beating up a weak version would be dishonest: the AIU is rigorous, six years proves cheating carries a price, and the deterrent is real. The clustering of tampering cases across Ethiopian and Kenyan road-racing squads makes that argument stronger, not weaker.

One fact still breaks it. Glucocorticoids have no proven endurance benefit. The sport has just closed six years of a career over a substance with no established evidence of making anyone faster. The actual failure sits elsewhere: a 2:18-class marathoner had no credentialed team physician, no TUE habit, and no adviser who said don't fabricate the slip, show the records. Nobody has been sanctioned for that failure. What we are calling a win against doping is, on the paperwork, a win for document verification. The word "steroid" hid the imbalance, because six years sounds proportionate for a steroid and raises questions for a glucocorticoid.

The next case is probably already sitting in the queue — same training cluster, same informal medical network, same old pads. When the AIU catches the next prescription is not in doubt. Whether it will ever audit the entourage, rather than keep reading the prescriptions, is the question worth carrying forward.

संबंधित खिलाड़ी